| Developers: | Bayer AG |
| Date of the premiere of the system: | February, 2017 |
| Branches: | Pharmaceutics, medicine, health care |
2017: Announcement
In the middle of February, 2017 the Bayer company provided a new injection system for magnetic resonance imaging. The range of the producer filled up the device Medrad MRXperion.
The device is used in magnetic resonance imaging to intravenous administration of magnitnokontrastny substance. The automated contrasting provides the maximum gain of contrast permission of fabrics.
Bayer calls Medrad MRXperion the first injection system for MRT using advanced information technologies. The equipment supports export of data to a management system for protocols of introduction of the contrast substances Bayer Radimetrics.
Besides, MRXperion can be connected to transmission systems and archiving of images (PACS), radiological information systems (RIS) and platforms of speech recognition for implementation of analytic functions and automation of access to documentation on introduction of contrast substances.
In the message of Bayer it is noted that MRXperion, as well as other products of the company, supports rapid implementation in work of the specialized medical commands and service specialists providing complex support of a system, minimizing expensive equipment downtime.
An injection system is designed for work in magnetic fields with high induction which takes place in modern MRT-researches. The color touch display and the intuitive interface simplify programming. In the device the function providing introduction of small doses of physical solution with the configured intervals in avoidance emergence of occlusions is implemented. Besides, the system of disposable components providing optimal contrasting is implemented.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |